Cancer Biology Research
CFDA 93.396 · Federal Grants & Funding
Total Funding
$6.67B
Awards
3K
Recipients
336
States
49
Last Updated
Mar 20, 2026
Yearly Funding Trend
| Fiscal Year | Obligations | Awards | YoY Change |
|---|---|---|---|
| 2024 | $5.64B | 2K | |
| 2025 | $908.0M | 548 | -83.9% |
| 2026 | $127.3M | 62 | -86.0% |
Award Type Mix
| Type | Obligations | Awards |
|---|---|---|
| $0 | 0 |
Top 50 Awards under CFDA 93.396
Largest individual obligations for Cancer Biology Research.
| Award | Recipient | Awarding Agency | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_P01CA013106_075 TARGETING TRANSCRIPTION AND SPLICING IN CANCER - OVERALL PROJECT SUMMARY THE OVERALL GOAL OF THIS PROGRAM IS TO UNDERSTAND HOW TRANSCRIPTION AND SPLICING REGULATION IS ALTERED AND… | COLD SPRING HARBOR LABORATORY New York | Department of Health and Human Services National Institutes of Health | COLD SPRING HARBOR, NY-03 | 2024 | $76,070,175 |
ASST_NON_P01CA101937_075 GENOMICS OF ACUTE MYELOID LEUKEMIA. - OVERVIEW: PROJECT SUMMARY/ABSTRACT THE LONG-TERM GOAL OF THE GENOMICS OF ACUTE MYELOID LEUKEMIA PROGRAM PROJECT GRANT (GAML PPG) IS TO DEFINE… | WASHINGTON UNIVERSITY, THE Missouri | Department of Health and Human Services National Institutes of Health | MO-90 | 2025 | $47,629,682 |
ASST_NON_P01CA117969_075 GENETICS AND BIOLOGY OF PANCREATIC DUCTAL ADENOCARCINOMA - OVERALL - ABSTRACT/SUMMARY. THIS MULTI-DISCIPLINARY TEAM FOCUSES ON THE ROLE OF ONCOGENIC KRAS (KRAS*) IN PANCREATIC… | THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER Texas | Department of Health and Human Services National Institutes of Health | HOUSTON, TX-09 | 2024 | $38,308,314 |
ASST_NON_P01CA022443_075 MOLECULAR BIOLOGY AND GENETICS OF HUMAN TUMOR VIRUSES - OVERALL – PROJECT SUMMARY/ABSTRACT MOLECULAR BIOLOGY AND GENETICS OF HUMAN TUMOR VIRUSES PAUL F. LAMBERT, PI VIRUSES CAUSE… | UNIVERSITY OF WISCONSIN SYSTEM Wisconsin | Department of Health and Human Services National Institutes of Health | MADISON, WI-02 | 2024 | $36,453,541 |
ASST_NON_P01CA100730_075 RETROVIRUS MODELS OF CANCER - OVERALL PROJECT SUMMARY THIS COMPETITIVE RENEWAL APPLICATION (P01CA100730) SEEKS FUNDS TO CONTINUE OUR HIGHLY INTEGRATED STUDIES OF RETROVIRUS MODELS… | OHIO STATE UNIVERSITY, THE Ohio | Department of Health and Human Services National Institutes of Health | COLUMBUS, OH-03 | 2024 | $31,069,673 |
ASST_NON_P01CA120964_075 MOLECULAR PATHOGENESIS OF THE HAMARTOMA SYNDROMES - OVERALL - PROJECT SUMMARY/ABSTRACT PLEASE SEE EACH PROJECT/CORE FOR INDIVIDUAL PROJECT SUMMARY/ABSTRACT | BRIGHAM & WOMENS HOSPITAL INC Massachusetts | Department of Health and Human Services National Institutes of Health | BOSTON, MA-07 | 2024 | $30,237,096 |
ASST_NON_P01CA019014_075 VIRAL ONCOGENESIS, LATENCY, AND REPLICATION - OVERALL PROJECT SUMMARY ABSTRACT THIS PROGRAM PROJECT GRANT APPLICATION FOCUSES ON THREE DNA TUMOR VIRUSES NAMELY HUMAN PAPILLOMAVIRU… | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL North Carolina | Department of Health and Human Services National Institutes of Health | CHAPEL HILL, NC-04 | 2024 | $29,305,262 |
ASST_NON_P01CA098101_075 MECHANISMS OF ESOPHAGEAL CARCINOGENESIS - PROJECT SUMMARY - OVERALL ESOPHAGEAL CANCER IS COMMON WORLDWIDE. THERE ARE TWO MAJOR SUBTYPES: ESOPHAGEAL SQUAMOUS CELL CANCER (ESCC) AND… | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK New York | Department of Health and Human Services National Institutes of Health | NY-90 | 2025 | $25,616,260 |
ASST_NON_P01CA116087_075 H. PYLORI-INDUCED INFLAMMATION AND GASTRIC CANCER - PROGRAM PROJECT GRANT OVERALL SUMMARY HELICOBACTER PYLORI IS THE STRONGEST RISK FACTOR FOR GASTRIC ADENOCARCINOMA, THE FOURTH L… | VANDERBILT UNIVERSITY MEDICAL CENTER Tennessee | Department of Health and Human Services National Institutes of Health | NASHVILLE, TN-07 | 2024 | $24,090,252 |
ASST_NON_P01CA093900_075 THE BIOLOGY OF PROSTATE CANCER SKELETAL METASTASES - OVERALL ABSTRACT THE COMMON OCCURRENCE, MARKED DEBILITATION AND SUBSEQUENT LETHALITY OF PROSTATE CANCER (PCA) SKELETAL METASTA… | REGENTS OF THE UNIVERSITY OF MICHIGAN Michigan | Department of Health and Human Services National Institutes of Health | MI-90 | 2024 | $23,799,725 |
ASST_NON_P01CA087497_075 ROLES AND REGULATION OF WILD-TYPE AND MUTANT FORMS OF P53 - OVERALL SUMMARY FOR THE PAST 15 YEARS OUR PROGRAM PROJECT CA87497 HAS BEEN HIGHLY PRODUCTIVE AND INTERACTIVE. THE FUTUR… | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK New York | Department of Health and Human Services National Institutes of Health | NEW YORK, NY-13 | 2024 | $23,064,716 |
ASST_NON_P01CA163227_075 ANDROGEN RECEPTOR ACTION IN CASTRATION RESISTANT PROSTATE CANCER - PROJECT SUMMARY A CENTRAL HYPOTHESIS THAT DROVE THE STUDIES PROPOSED IN THE CURRENTLY FUNDED P01 WAS THAT ANDROG… | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. Massachusetts | Department of Health and Human Services National Institutes of Health | MA-90 | 2025 | $19,661,882 |
ASST_NON_P01CA098912_075 PROSTATE CANCER BONE METASTASIS BIOLOGY AND TARGETING - DESCRIPTION (PROVIDED BY APPLICANT): LETHAL BONE METASTASIS FREQUENTLY DEVELOPS IN PATIENTS WITH CASTRATION-RESISTANT PROST… | CEDARS-SINAI MEDICAL CENTER California | Department of Health and Human Services National Institutes of Health | CA-90 | 2024 | $18,015,281 |
ASST_NON_P01CA214091_075 NONCODING RNAS IN GAMMA-HERPESVIRUS BIOLOGY AND AIDS MALIGNANCIES - SUMMARY THE GOAL OF THIS PROGRAM IS TO USE COMPARATIVE ANALYSIS OF KSHV, EBV AND MHV68 SHORT AND LONG NONCODING… | UNIVERSITY OF FLORIDA Florida | Department of Health and Human Services National Institutes of Health | GAINESVILLE, FL-03 | 2024 | $14,239,850 |
ASST_NON_R01CA089713_075 MOUSE MODELS OF HUMAN CANCER DATABASE - PROJECT SUMMARY/ABSTRACT THE LABORATORY MOUSE IS THE PREEMINENT ANIMAL MODEL SYSTEM FOR INVESTIGATION INTO THE BIOLOGY AND GENETICS OF HUMA… | JACKSON LABORATORY Maine | Department of Health and Human Services National Institutes of Health | BAR HARBOR, ME-02 | 2024 | $13,183,172 |
ASST_NON_U24CA213274_075 COORDINATING CENTER FOR THE NCI SMALL CELL LUNG CANCER RESEARCH CONSORTIUM - ABSTRACT THE OVERARCHING GOAL OF THE NCI SMALL CELL LUNG CANCER (SCLC) COORDINATING CENTER HAS BEEN TO… | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH New York | Department of Health and Human Services National Institutes of Health | NEW YORK, NY-12 | 2024 | $11,732,558 |
ASST_NON_R01CA075922_075 RHESUS HHV-8 HOMOLOGUE IN AIDS-RELATED MALIGNANCIES - PROJECT SUMMARY/ABSTRACT VIRUSES CAUSE AN ARRAY OF DISEASE MANIFESTATIONS RANGING FROM ACUTE RESPIRATORY DISEASE, INTESTINAL… | OREGON HEALTH & SCIENCE UNIVERSITY Oregon | Department of Health and Human Services National Institutes of Health | PORTLAND, OR-01 | 2024 | $11,504,567 |
ASST_NON_R35CA197583_075 DISSECTING AND TARGETING DEREGULATED MITOCHONDRIAL APOPTOSIS IN HUMAN CANCER - PROJECT SUMMARY/ABSTRACT BCL-2 PROTEINS PARTICIPATE IN A DYNAMIC INTERACTION NETWORK THAT DETERMINES… | DANA-FARBER CANCER INSTITUTE, INC. Massachusetts | Department of Health and Human Services National Institutes of Health | BOSTON, MA-07 | 2024 | $11,425,117 |
ASST_NON_R35CA197623_075 TARGETING INTRATUMOR HETEROGENEITY IN BREAST CANCER - PROJECT SUMMARY: BREAST CANCER IS THE MOST COMMON CANCER AND THE LEADING CAUSE OF CANCER DEATHS IN WOMEN WORLD- WIDE. WHILE T… | DANA-FARBER CANCER INSTITUTE, INC. Massachusetts | Department of Health and Human Services National Institutes of Health | BOSTON, MA-07 | 2024 | $11,353,199 |
ASST_NON_R01CA053840_075 PROTEIN TYROSINE DEPHOSPHORYLATION & SIGNAL TRANSDUCTION - PROJECT SUMMARY/ ABSTRACT THE FIRST DRUGS DIRECTED AGAINST PROTEIN TYROSINE KINASES (PTKS) HAVE NOW ENTERED THE MARKET A… | COLD SPRING HARBOR LABORATORY New York | Department of Health and Human Services National Institutes of Health | COLD SPRING HARBOR, NY-03 | 2024 | $11,265,836 |
ASST_NON_P01CA165997_075 THE ROLE OF THE INTEGRATED STRESS RESPONSE IN CANCER - ABSTRACT/SUMMARY (OVERALL) THE OVERALL GOAL OF THIS PROGRAM IS TO INVESTIGATE THE ROLE OF THE INTEGRATED STRESS RESPONSE (IS… | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE Pennsylvania | Department of Health and Human Services National Institutes of Health | PA-90 | 2026 | $10,859,506 |
ASST_NON_P01CA234228_075 APOBEC MUTAGENESIS IN BREAST CANCER - OVERALL – APOBEC MUTAGENESIS IN BREAST CANCER ABSTRACT APOBEC SIGNATURE MUTATIONS MAKE UP 20% OF BASE-SUBSTITUTION MUTATIONS IN PRIMARY TUMO… | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO Texas | Department of Health and Human Services National Institutes of Health | SAN ANTONIO, TX-20 | 2025 | $10,707,319 |
ASST_NON_R35CA197628_075 METABOLIC GATEKEEPERS IN B-CELL MALIGNANCIES - ABSTRACT THE INTRODUCTION OF SMALL MOLECULE INHIBITORS OF KINASES DOWNSTREAM OF THE B-CELL RECEPTOR (BCR) OR ITS ONCOGENIC MIMICS SU… | YALE UNIV Connecticut | Department of Health and Human Services National Institutes of Health | NEW HAVEN, CT-03 | 2024 | $10,701,847 |
ASST_NON_R35CA197745_075 PREDICTING CANCER CELL RESPONSE TO ENDOGENOUS AND EXOGENOUS PERTURBATIONS AT THE SINGLE CELL LEVEL - THE STUDY OF CANCER HAS BEEN PREDICATED ON THE DISCOVERY OF INDIVIDUAL EVENTS,… | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK New York | Department of Health and Human Services National Institutes of Health | NEW YORK, NY-13 | 2024 | $10,498,305 |
ASST_NON_P01CA245705_075 SEX-BASED DIFFERENCES IN GLIOMA - PROJECT SUMMARY GLIOBLASTOMA (GBM), THE MOST COMMON PRIMARY MALIGNANT BRAIN TUMOR, REMAINS UNIFORMLY LETHAL DESPITE AGGRESSIVE THERAPIES. EPIDEMI… | CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE OF CASE WESTERN RESERVE UNIVERSITY Ohio | Department of Health and Human Services National Institutes of Health | CLEVELAND, OH-11 | 2024 | $10,414,912 |
ASST_NON_R35CA197695_075 TRANSLATING GENOMIC DISCOVERIES TO IMPROVED OUTCOMES FOR HIGH RISK ACUTE LEUKEMIA - ABSTRACT ACUTE LEUKEMIA IS A LEADING CAUSE OF DEATH IN THE YOUNG. THE GOAL OF MY RESEARCH PROGR… | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC Tennessee | Department of Health and Human Services National Institutes of Health | MEMPHIS, TN-09 | 2024 | $10,372,840 |
ASST_NON_R35CA197594_075 SYNERGISTIC ROLE OF SIGNALING AND EPIGENETICS IN LEUKEMIC TRANSFORMATION - PROJECT ABSTRACT WE PROPOSE TO USE SINGLE CELL STUDIES OF CLINICAL ISOLATES TO EXPLICATE HOW MUTATIONS A… | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH New York | Department of Health and Human Services National Institutes of Health | NEW YORK, NY-12 | 2024 | $10,340,346 |
ASST_NON_R35CA197699_075 MOLECULAR STRATEGIES FOR EARLY DETECTION AND TARGETING OF CANCER - SUMMARY CANCER PROGRESSION AND RELAPSE REMAIN THE REALITY OF CURRENT CANCER THERAPY. OUR WORK IS AIMED AT UNDERS… | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK New York | Department of Health and Human Services National Institutes of Health | NY-90 | 2024 | $10,300,524 |
ASST_NON_R35CA197622_075 LIVE-CELL ACTIVITY ARCHITECTURE IN CANCER - PROJECT SUMMARY: ESSENTIAL REGULATION OF THE CELLULAR MACHINERY IS ACHIEVED BY A NETWORK OF HIGHLY DYNAMIC SIGNALING MOLECULES, WHICH,… | UNIVERSITY OF CALIFORNIA, SAN DIEGO California | Department of Health and Human Services National Institutes of Health | LA JOLLA, CA-50 | 2024 | $10,207,742 |
ASST_NON_R35CA220538_075 DECODING AND TARGETING THE LKB1-AMPK SIGNALING PATHWAY IN CANCER - PROJECT SUMMARY. THE AIM OF THIS PROJECT IS TO DECODE NEW COMPONENTS OF THE LKB1 TUMOR SUPPRESSOR PATHWAY TO THE… | SALK INSTITUTE FOR BIOLOGICAL STUDIES, SAN DIEGO, CALIFORNIA, THE California | Department of Health and Human Services National Institutes of Health | LA JOLLA, CA-50 | 2024 | $10,178,788 |
ASST_NON_P01CA250984_075 IDENTIFYING METABOLIC VULNERABILITIES IN LUNG CANCER - OVERALL PROJECT SUMMARY IDENTIFYING METABOLIC VULNERABILITIES IN LUNG CANCER LUNG CANCER IS THE MOST COMMON CAUSE OF CANCER… | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. Florida | Department of Health and Human Services National Institutes of Health | TAMPA, FL-15 | 2024 | $10,093,168 |
ASST_NON_R35CA197561_075 MOLECULAR PATHOGENESIS OF ACUTE MYELOID LEUKEMIA - PROJECT SUMMARY THE LONG-TERM GOAL OF THIS PROJECT IS TO DEVELOP EFFECTIVE, PRECISION THERAPIES DIRECTED AGAINST THE INITIATING… | WASHINGTON UNIVERSITY, THE Missouri | Department of Health and Human Services National Institutes of Health | SAINT LOUIS, MO-01 | 2024 | $10,052,833 |
ASST_NON_P01CA244114_075 PANCREATIC CANCER DEVELOPMENT: GENETIC AND IMMUNE REGULATION - ABSTRACT (OVERALL): PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IS A DEADLY DISEASE WHOSE MECHANISMS OF DEVELOPMENT REMA… | THE LELAND STANFORD JUNIOR UNIVERSITY California | Department of Health and Human Services National Institutes of Health | STANFORD, CA-16 | 2024 | $10,028,938 |
ASST_NON_R35CA197459_075 DECODING AND TARGETING THE PI3K-MTOR SIGNALING NETWORK IN CANCER - ABSTRACT THE MAJOR GROWTH FACTOR SIGNALING PATHWAYS IN NORMAL CELLS (E.G., PI3K AND RAS) ARE ALSO THE ONES THAT… | PRESIDENT AND FELLOWS OF HARVARD COLLEGE Massachusetts | Department of Health and Human Services National Institutes of Health | BOSTON, MA-07 | 2024 | $9,825,427 |
ASST_NON_P01CA236778_075 THE ROLE OF THE MACROENVIRONMENT IN PANCREATIC CANCER-INDUCED CACHEXIA - PROJECT SUMMARY: OVERALL THE OVERALL GOAL OF THIS PROGRAM PROJECT IS TO GAIN A BETTER UNDERSTANDING OF THE… | THE MEDICAL UNIVERSITY OF SOUTH CAROLINA South Carolina | Department of Health and Human Services National Institutes of Health | CHARLESTON, SC-06 | 2024 | $9,697,215 |
ASST_NON_P01CA233452_075 DETERMINANTS OF LIVER METASTASIS - PROGRAM TITLE: DETERMINANTS OF LIVER METASTASIS PROGRAM ABSTRACT LIVER METASTASIS INDICATES A TERMINAL ILLNESS FOR MANY CANCERS AND IS A LEADING… | CEDARS-SINAI MEDICAL CENTER California | Department of Health and Human Services National Institutes of Health | CA-90 | 2024 | $9,538,426 |
ASST_NON_P01CA254849_075 INTEGRATED IMMUNE ENGINEERING FOR POOR PROGNOSIS CANCERS - ABSTRACT A KEY LIMITATION TO EFFECTIVE IMMUNOTHERAPY IS THE PHYSICAL ACCESS OF IMMUNE CELLS TO THE CANCER CELLS. WE PROP… | REGENTS OF THE UNIVERSITY OF MINNESOTA Minnesota | Department of Health and Human Services National Institutes of Health | MN-90 | 2024 | $9,378,487 |
ASST_NON_R01CA046595_075 MITOGENIC AND ONCOGENIC REGULATION OF ERK/RSK SIGNALING - CANCER IS THE 2ND LEADING CAUSE OF DEATH IN THE US. THE ADVENT OF NEW TREATMENTS SUCH AS IMMUNOTHERAPY AND TARGETED THERA… | WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY New York | Department of Health and Human Services National Institutes of Health | NEW YORK, NY-12 | 2024 | $9,203,389 |
ASST_NON_P01CA265768_075 INVESTIGATING CELL-INTRINSIC AND EXTRINSIC INTERACTIONS IN PROSTATE CANCER AT THE SINGLE CELL LEVEL - PROJECT SUMMARY/ABSTRACT PROSTATE CANCER PROGRESSION TO METASTATIC CASTRATIO… | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK New York | Department of Health and Human Services National Institutes of Health | NEW YORK, NY-13 | 2024 | $9,198,747 |
ASST_NON_R35CA197588_075 ROLE OF PHOSPHOINOSITIDES AND PROTEIN KINASES IN THE CONTROL OF CANCER METABOLISM - PROJECT SUMMARY/ABSTRACT PREVIOUS WORK FUNDED BY THIS R35 GRANT LED TO THE DISCOVERY THAT ONCOG… | DANA-FARBER CANCER INSTITUTE, INC. Massachusetts | Department of Health and Human Services National Institutes of Health | BOSTON, MA-07 | 2024 | $9,179,621 |
ASST_NON_R35CA210088_075 THE ROLE OF STEM CELLS AND THE MICROENVIRONMENT IN GASTROINTESTINAL CANCERS - SUMMARY/ABSTRACT TIMOTHY C. WANG, NCI R35 GASTROINTESTINAL (GI) CANCERS MOST OFTEN ARISE IN THE SETTI… | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK New York | Department of Health and Human Services National Institutes of Health | NEW YORK, NY-13 | 2024 | $9,168,821 |
ASST_NON_R35CA210105_075 FROM PATHOGENESIS TO NEW THERAPEUTIC TARGETS IN DIFFUSE LARGE B CELL LYMPHOMA - PROJECT SUMMARY DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IS INCURABLE IN ~30% OF PATIENTS AND, DESPITE… | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK New York | Department of Health and Human Services National Institutes of Health | NEW YORK, NY-13 | 2024 | $9,029,650 |
ASST_NON_P01CA265748_075 MODIFIABLE DRIVERS OF EXPANSION AND MALIGNANT TRANSFORMATION FROM CLONAL HEMATOPOIESIS - PROJECT SUMMARY/ABSTRACT CLONAL HEMATOPOIESIS (CH) IS AN AGE-ASSOCIATED PRE-MALIGNANT COND… | BAYLOR COLLEGE OF MEDICINE Texas | Department of Health and Human Services National Institutes of Health | HOUSTON, TX-09 | 2024 | $9,029,147 |
ASST_NON_P01CA265762_075 OVERCOMING MECHANISMS OF THERAPEUTIC RESISTANCE IN PANCREATIC DUCTAL ADENOCARCINOMA - PROJECT SUMMARY – OVERALL WHILE MORTALITY RATES FOR MANY CANCERS ARE DECLINING, PANCREATIC DU… | SALK INSTITUTE FOR BIOLOGICAL STUDIES, SAN DIEGO, CALIFORNIA, THE California | Department of Health and Human Services National Institutes of Health | LA JOLLA, CA-50 | 2024 | $8,782,037 |
ASST_NON_U24CA232979_075 IMMUNO-ONCOLOGY TRANSLATION NETWORK: DATA MANAGEMENT AND RESOURCE-SHARING CENTER AT RPCI - PROJECT SUMMARY WHILE SEVERAL INNOVATIVE AND CREATIVE IMMUNO-ONCOLOGY (IO) STRATEGIES HA… | HEALTH RESEARCH, INC. New York | Department of Health and Human Services National Institutes of Health | BUFFALO, NY-26 | 2024 | $8,764,855 |
ASST_NON_P01CA229123_075 EXRNA IN COLORECTAL CARCINOMA: BIOGENESIS AND FUNCTION - SUMMARY – OVERALL COMPONENT CELLULAR COMMUNICATION BETWEEN DIVERSE CELLS IS NOW RECOGNIZED TO HEAVILY INFLUENCE BOTH CANCE… | VANDERBILT UNIVERSITY Tennessee | Department of Health and Human Services National Institutes of Health | NASHVILLE, TN-05 | 2024 | $8,758,820 |
ASST_NON_P01CA233412_075 INFORMED COMBINATION STRATEGIES FOR PERIPHERAL T-CELL LYMPHOMAS - PROJECT SUMMARY DESPITE ADVANCES IN THE TREATMENT OF MANY HEMATOLOGIC MALIGNANCIES, PATIENTS WITH PERIPHERAL T-CE… | DANA-FARBER CANCER INSTITUTE, INC. Massachusetts | Department of Health and Human Services National Institutes of Health | MA-90 | 2025 | $8,725,418 |
ASST_NON_P01CA250959_075 NEW THERAPEUTIC VULNERABILITIES IN BREAST CANCER - PROJECT SUMMARY/ABSTRACT THIS PROPOSAL DESCRIBES THE EXISTING AND PROPOSED FUTURE ACTIVITIES OF A CONSORTIUM OF THREE RESEARCH G… | DANA-FARBER CANCER INSTITUTE, INC. Massachusetts | Department of Health and Human Services National Institutes of Health | BOSTON, MA-07 | 2024 | $8,630,014 |
ASST_NON_R35CA220449_075 HUMAN METABOLIC VARIATION AS A WINDOW INTO CANCER INITIATION AND PROGRESSION - PROJECT SUMMARY/ABSTRACT METABOLIC REPROGRAMMING IS A HALLMARK OF MALIGNANCY AND POTENTIAL SOURCE OF… | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER Texas | Department of Health and Human Services National Institutes of Health | DALLAS, TX-30 | 2024 | $8,456,318 |
ASST_NON_R35CA197570_075 EARLY TO LATE EVENTS IN COLORECTAL NEOPLASIA: BASIC BIOLOGY TO CLINICAL IMPLEMENTATION - PROJECT SUMMARY/ABSTRACT THE FOCUS OF THIS RENEWAL REMAINS COLORECTAL CANCER (CRC), THE 2N… | VANDERBILT UNIVERSITY MEDICAL CENTER Tennessee | Department of Health and Human Services National Institutes of Health | NASHVILLE, TN-05 | 2024 | $8,367,059 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Spending by State
| State | Funding | Awards |
|---|---|---|
| New York | $1.10B | 410 |
| California | $920.5M | 389 |
| Massachusetts | $648.8M | 245 |
| Texas | $576.8M | 283 |
| Pennsylvania | $448.5M | 211 |
| Ohio | $243.1M | 124 |
| North Carolina | $231.9M | 100 |
| Florida | $225.8M | 106 |
| Illinois | $210.4M | 110 |
| Michigan | $178.7M | 79 |
| Tennessee | $177.1M | 51 |
| Missouri | $154.2M | 55 |
| Washington | $150.1M | 68 |
| Wisconsin | $135.6M | 50 |
| Maryland | $132.7M | 83 |
| Connecticut | $121.0M | 52 |
| Minnesota | $85.4M | 44 |
| Georgia | $83.9M | 41 |
| New Jersey | $81.5M | 46 |
| Indiana | $77.8M | 43 |
| Oregon | $71.3M | 31 |
| Colorado | $68.3M | 46 |
| Virginia | $65.5M | 41 |
| Alabama | $54.2M | 36 |
| Utah | $47.6M | 27 |
| Kentucky | $43.8M | 24 |
| South Carolina | $39.6M | 20 |
| Louisiana | $37.9M | 24 |
| District of Columbia | $37.4M | 21 |
| Arizona | $33.1M | 17 |
| Nebraska | $32.9M | 19 |
| New Hampshire | $24.7M | 13 |
| Oklahoma | $23.9M | 16 |
| Maine | $19.0M | 4 |
| Iowa | $13.4M | 7 |
| Arkansas | $11.1M | 7 |
| Kansas | $8.7M | 6 |
| Rhode Island | $7.9M | 15 |
| New Mexico | $7.8M | 4 |
| Hawaii | $6.4M | 3 |
| Puerto Rico | $6.2M | 6 |
| Vermont | $4.6M | 4 |
| Delaware | $2.9M | 2 |
| Nevada | $2.5M | 4 |
| South Dakota | $1.4M | 3 |
| Idaho | $827K | 2 |
| Mississippi | $709K | 2 |
| Montana | $364K | 1 |
| West Virginia | $50K | 1 |
Top Recipients
Agencies Administering This Program
Source: USAspending.gov · All Programs